SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-22-020119
Filing Date
2022-08-11
Accepted
2022-08-11 16:10:58
Documents
99
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nby20220630_10q.htm   iXBRL 10-Q 1446658
2 EXHIBIT 31.1 ex_401819.htm EX-31.1 7913
3 EXHIBIT 31.2 ex_401820.htm EX-31.2 8067
4 EXHIBIT 32.1 ex_401821.htm EX-32.1 4181
5 EXHIBIT 32.2 ex_401822.htm EX-32.2 3918
  Complete submission text file 0001437749-22-020119.txt   8691422

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA nby-20220630.xsd EX-101.SCH 95565
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nby-20220630_cal.xml EX-101.CAL 55417
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20220630_def.xml EX-101.DEF 555469
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20220630_lab.xml EX-101.LAB 489571
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20220630_pre.xml EX-101.PRE 602080
93 EXTRACTED XBRL INSTANCE DOCUMENT nby20220630_10q_htm.xml XML 1587736
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33678 | Film No.: 221155833
SIC: 2834 Pharmaceutical Preparations